ALLIANCE PHARMACEUTICAL CORP
S-8, 1995-06-05
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: ALLIANCE PHARMACEUTICAL CORP, S-8, 1995-06-05
Next: 3COM CORP, 8-K/A, 1995-06-05



   As filed with the Securities and Exchange Commission on June
2, 1995
                                                                

                                  Registration Statement No. 33-
                    SECURITIES AND EXCHANGE COMMISSION
                          Washington, D.C. 20549
                                               

                                 FORM S-8
                       REGISTRATION STATEMENT UNDER
                        THE SECURITIES ACT OF 1933
                                               

                       ALLIANCE PHARMACEUTICAL CORP.
          (Exact name of registrant as specified in its charter)

                   New York                  14-1644018
         (State or other jurisdiction    (I.R.S. Employer
     of incorporation or organization)   Identification Number) 
                          3040 Science Park Road
                           San Diego, CA  92121
                              (619) 558-4300           (Address,
including zip code, and telephone number,
including area code of registrant's principal executive offices)

          EMPLOYEES 401(K) PLAN OF ALLIANCE PHARMACEUTICAL CORP.
                         (Full title of the plan)

                               DUANE J. ROTH
                                 President
                       Alliance Pharmaceutical Corp.
                          3040 Science Park Road
                           San Diego, CA  92121
                              (619) 558-4300
               (Name, address, including zip code, and telephone
number, of agent for service of process)
                                               

                                 Copy to:
                           Melvin Epstein, Esq.
                         Stroock & Stroock & Lavan
                           Seven Hanover Square
                         New York, NY  10004-2696
                                               
<TABLE>
<CAPTION>
                      CALCULATION OF REGISTRATION FEE

                                     Proposed      Proposed                  
                                     Maximum       Maximum                   
  Title of Shares                    Aggregate     Aggregate   Amount of     
  to be             Amount to be     Price Per     Offering    Registration  
  Registered        Registered       Unit (1)      Price       Fee           
  <S>                  <C>           <C>         <C>             <C>
  Common Stock,        24,979        $6.00 per                               
  $.01 par value.      shares        share       $149,874.00     $100.00     

</TABLE>

     (1)  As dictated by Rule 457(h)(1), the Proposed Maximum
          Aggregate Price Per Unit represents the amount per
          share at which the Company values its matching
          contribution under the Employees' 401(k) Plan of
          Alliance Pharmaceutical Corp.
<PAGE>


     This Registration Statement on Form S-8 of Alliance
Pharmaceutical Corp., a New York corporation (the "Company"),
covers 24,979 shares of Common Stock, par value $.01 per share,
of the Company reserved for issuance under the Employees'
401(k) Plan of Alliance Pharmaceutical Corp.  As permitted by
General Instruction E of Form S-8, the Company hereby
incorporates by reference the contents of the Company's
Registration Statement on Form S-8, dated March 31, 1994
(Registration No. 33-77172) filed under the 1933 Act.
<PAGE>


                                SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933,
the Registrant certifies that it has reasonable grounds to
believe that it meets all of the requirements for filing on Form
S-8 and has duly caused this Registration Statement to be signed
on its behalf by the undersigned, thereunto duly authorized, in
the City of San Diego, State of California, on June 2, 1995.

                               ALLIANCE PHARMACEUTICAL CORP.
                                     (Registrant)


Date: June 2, 1995               By  /s/ Duane J. Roth          

                                    Duane J. Roth
                                     President

                                     
     Pursuant to the requirements of the Securities Act of 1933,
this Registration Statement has been signed below by the
following persons in the capacities indicated on June 2, 1995.


/s/Duane J. Roth        President, Chief Executive
   Duane J. Roth        Officer and a Director     June 2, 1995
   (Chief Executive Officer)


/s/Theodore D. Roth    Executive Vice President
   Theodore D. Roth    and Chief Financial Officer  June 2, 1995
   (Chief Financial Officer)


/s/Tim T. Hart        Treasurer and Comptroller     June 2, 1995
   Tim T. Hart
   (Chief Accounting Officer)

   Carroll O. Johnson*    Director               June 2, 1995
   Carroll O. Johnson

   Stephen M. McGrath*    Director               June 2, 1995
   Stephen M. McGrath

   Donald E. O'Neill*     Director               June 2, 1995
   Donald E. O'Neill

   Dr. Helen M. Ranney*   Director               June 2, 1995
   Dr. Helen M. Ranney

   Dr. Jean G. Riess*     Director               June 2, 1995
   Dr. Jean G. Riess

   Dr. Thomas F. Zuck*    Director               June 2, 1995
   Dr. Thomas F. Zuck

 *  By:/s/ Theodore D. Roth                      
        Theodore D. Roth
        Attorney-in-Fact
<PAGE>

                               EXHIBIT INDEX
                                                      
Sequential
Exhibit                                            Page      
Number                  Description                Number    

 5            Opinion of Stroock & Stroock & Lavan.             
23.1          Consent of Stroock & Stroock & Lavan (included in
             Exhibit 5 hereto).
23.2          Consent of Deloitte & Touche LLP.
23.3          Consent of Ernst & Young LLP.
24            Power of Attorney.


                                                 EXHIBIT 5


            [LETTERHEAD OF STROOCK & STROOCK & LAVAN]

 
June 2, 1995

Alliance Pharmaceutical Corp.
3040 Science Park Road
San Diego, CA 92121

Re:  Alliance Pharmaceutical Corp.
     Registration Statement on Form S-8

Ladies and Gentlemen:

We have acted as counsel to you (the "Company") in connection
with the preparation and filing of the above-captioned
Registration Statement on Form S-8 (the "Registration
Statement") under the Securities Act of 1933, as amended (the
"Act"), covering 24,979 shares of the Company's Common Stock,
par value $.01 per share (the "Shares").  The Shares are
issuable pursuant to the Employees' 401(k) Plan of Alliance
Pharmaceutical Corp. (the "Plan"). 

We have examined copies of the Certificate of Incorporation and
By-laws of the Company, each as amended to date, the Plan, the
minutes of various meetings of the Board of Directors of the
Company and the original, photostatic or certified copies of all
such records of the Company, and all such agreements,
certificates of public officials, certificates of officers and
representatives of the Company or others, and such other
documents, papers, statutes and authorities as we deemed
necessary to form the basis of the opinions hereinafter
expressed.  In such examination, we have assumed the genuineness
of signatures and the conformity to original documents of the
documents supplied to us as copies.  As to various questions of
fact material to such opinions, we have relied upon
statements and certificates of officers of the Company and
others.

Based upon the foregoing, we are of the opinion that all of the
Shares covered by the Registration Statement have
been duly authorized and, when issued in accordance with the
terms of the Plan, will be validly issued, fully paid
and nonassessable.

We hereby consent to your filing a copy of this opinion as an
exhibit to the Registration Statement.  In giving such
consent, we do not admit hereby that we come within the category
of persons whose consent is required under Section 7 of the Act,
or the rules and regulations of the Securities and Exchange
Commission thereunder.

Very truly yours,

/s/STROOCK & STROOCK & LAVAN
<PAGE>
                                                EXHIBIT 23.2

INDEPENDENT AUDITORS' CONSENT

We consent to the incorporation by reference in this
Registration Statement of Alliance Pharmaceutical Corp. on
Form S-8 of our report dated July 27, 1993, appearing in the
Annual Report on Form 10-K of Alliance Pharmaceutical Corp. (the
"Company") for the year ended June 30, 1994, as amended by the
Company's Amended Annual Report on Form 10-K/A filed March 7,
1995.


/s/ DELOITTE & TOUCHE LLP

New York, New York
May 30, 1995
<PAGE>
                                                 EXHIBIT 23.3

CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS


We consent to the incorporation by reference in the Registration
Statement (Form S-8) pertaining to the Employees 401(k) Plan of
Alliance Pharmaceutical Corp. of our report dated August 16,
1994, with respect to the consolidated financial statements and
schedule of Alliance Pharmaceutical Corp. included in its Annual
Report (Form 10-K), as amended by Form 10-K/A, for the year
ended June 30, 1994, filed with the securities and Exchange
Commission.


/s/ ERNST & YOUNG LLP

San Diego, California
May 30, 1995
<PAGE>
                                                EXHIBIT 24
                         POWER OF ATTORNEY

          KNOW ALL MEN BY THESE PRESENTS, that each person whose
signature appears below constitutes and appoints Duane J. Roth
and Theodore D. Roth, or either of them, his true and lawful
attorney-in-fact and agent, with full power of substitution and
resubstitution, for him and in his name, place and stead, in any
and all capacities, to sign a registration statement on Form S-8
(or an amendment to a previously filed registration
statement on Form S-8) or such other form as counsel to Alliance
Pharmaceutical Corp. (the "Corporation") may recommend in
connection with the registration of common stock of the
Corporation issued to employees of the Corporation as of
December 31, 1994, pursuant to the Corporation's 401(k) Plan,
and any and all amendments to this registration statement, and
to file the same, with all exhibits thereto, and other documents
in connection therewith, with the Securities and Exchange
Commission, granting unto said attorney-in-fact and agent full
power and authority to do and perform each and every act and
thing requisite and necessary to be done in and about the
premises, as fully to all intents and purposes as he might or
could do in person, hereby ratifying and confirming all
that said attorney-in-fact, agent, or their substitutes may
lawfully do or cause to be done by virtue hereof.

          IN WITNESS WHEREOF, each of the undersigned has caused
this power of attorney to be executed as of the date set forth
beside their name.


    /s/ Carroll O. Johnson    Director       April 1, 1995
        Carroll O. Johnson

    /s/ Stephen M. McGrath    Director       April 1, 1995
        Stephen M. McGrath

    /s/ Helen M. Ranney       Director       April 3, 1995
        Helen M. Ranney, M.D.


    /s/ Donald E. O'Neill     Director       April 1, 1995
        Donald E. O'Neill

    /s/ Jean Riess, Ph.D.     Director       April 1, 1995
        Jean Riess, Ph.D.

    /s/ Thomas F. Zuck, M.D.  Director       April 1, 1995
        Thomas F. Zuck, M.D.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission